UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043284
Receipt number R000047951
Scientific Title Evaluation of surgical outcome after endoscopic dacryocystorhinostomy
Date of disclosure of the study information 2021/05/01
Last modified on 2021/02/09 12:27:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of surgical outcome after endoscopic dacryocystorhinostomy

Acronym

Surgical outcome of endoscopic DCR

Scientific Title

Evaluation of surgical outcome after endoscopic dacryocystorhinostomy

Scientific Title:Acronym

Surgical outcome of endoscopic DCR

Region

Japan


Condition

Condition

nasolacrimal duct obstruction,dacryocystitis

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate outcomes and prognostic factors of endoscopic DCR perfomed at Japanese Red Cross Osaka Hosopital and Hyogo Prefectural Amagasaki General Medical Center.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Anatomic patency based on lacrimal irrigation before surgery, 7 weeks after surgery, and 52 weeks after surgery.

Key secondary outcomes

1.Assessment of change in tear meniscus height measured by anterior segment optical coherence tomography.
2.Quantitative assessment of improvement in subjective symptoms scored by tree-grade evaluation as follows: (1)complete resolution,(2)moderate epiphora,(3)no improvement
These evaluations were performed before surgery, 7 weeks after surgery, and 52 weeks after surgery.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1.The cases of nasolacrimal duct obstruction,acute and chronic dacryocystitis.
2.The case that have never undergone prior external and/or endoscopic DCR.

Key exclusion criteria

1.The case in which the part of obstruction is proximal to common canaliculus.
2.The case undergone endoscopic sinus surgery at the same time of endoscopic DCR.
3.The case of which consent can't be obtained from the patients.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Hiroko
Middle name
Last name Matsuyama

Organization

Japanese Red Cross Osaka Hosopital

Division name

Ophthalmology

Zip code

543-8555

Address

5-30 Fudegasakicho, Tennoji-ku,Osaka

TEL

0667745111

Email

hospital@osaka-med.jrc.or.jp


Public contact

Name of contact person

1st name Hiroko
Middle name
Last name Matsuyama

Organization

Japanese Red Cross Osaka Hosopital

Division name

Ophthalmology

Zip code

543-8555

Address

5-30 Fudegasakicho, Tennoji-ku,Osaka

TEL

0667745111

Homepage URL

https://www.osaka-med.jrc.or.jp/aboutus/information/ethics.html

Email

hospital@osaka-med.jrc.or.jp


Sponsor or person

Institute

Japanese Red Cross Osaka Hosopital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hyougo Prefectural Amagasaki General Medical Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japanese Red Cross Osaka Hosopital

Address

5-30 Fudegasakicho, Tennoji-ku,Osaka

Tel

0667745111

Email

hospital@osaka-med.jrc.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪赤十字病院、兵庫県立尼崎総合医療センター


Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 04 Month 01 Day

Date of IRB

2020 Year 09 Month 04 Day

Anticipated trial start date

2018 Year 05 Month 01 Day

Last follow-up date

2022 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2021 Year 02 Month 09 Day

Last modified on

2021 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047951


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name